TNFα regulates the localization of CD40 in lipid rafts of glioma cells
- 345 Downloads
Resistance of glioblastoma multiforme (GBM) to TNFα induced apoptosis is attributed to NFκB activation. As TNF-receptor family member CD40 regulates NFκB activation, we investigated the role of CD40 in NFκB activation in GBM. We observed elevated CD40 levels in human glioma samples as compared to the surrounding normal tissue. Treatment with TNFα elevated CD40 levels in glioma cells and inhibition of CD40 signaling failed to abrogate TNFα induced NFκΒ activity. While TNFα increased the interaction between TRAF2/6, IκBα, IKKα/β in the CD40 signalosome, the level of CD40 in the signalosome remained unaffected upon TNFα treatment. Interestingly, TNFα decreased the spatial localization of CD40 and increased TRAF2/6 co-localization with lipid raft marker Caveolin. As localization of CD40 signalosome in lipid raft is crucial for NFκB activation, TNFα mediated decreased clustering of CD40 in lipid rafts could have possibly contributed to its non-involvement in NFκB activation.
KeywordsTNFα CD40 NFκB Glioma Lipid rafts
This work was supported by the Innovative Young Biotechnologist Award (IYBA) research grant from the Department of Biotechnology, Government of India, to ES.
- 6.Tewari R, Choudhury SR, Ghosh S, Mehta VS, Sen E (2012) Involvement of TNFalpha-induced TLR4-NF-kappaB and TLR4-HIF-1alpha feed-forward loops in the regulation of inflammatory responses in glioma. J Mol Med 90(1):67–80Google Scholar
- 7.Sharma V, Tewari R, Sk UH, Joseph C, Sen E (2008) Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex. Int J Cancer 123(9):2204–2212CrossRefPubMedGoogle Scholar
- 8.Dixit D, Sharma V, Ghosh S, Mehta VS, Sen E Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFalpha)-induced apoptosis through SIRT1 inhibition. Cell Death Dis 3(2):e271Google Scholar
- 10.Zhou Y, He J, Gou LT, Mu B, Liao WC, Ma C et al Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells. Cancer Immunol Immunother Mar 11 [Epub ahead of print]Google Scholar
- 11.Posner MR, Cavacini LA, Upton MP, Tillman KC, Gornstein ER, Norris CM Jr (1999) Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines. Clin Cancer Res 5(8):2261–2270PubMedGoogle Scholar
- 13.Xie F, Shi Q, Wang Q, Ge Y, Chen Y, Zuo J et al (2010) CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma. J Neuroimmunol 222(1–2):62–69Google Scholar
- 14.Tewari R, Sharma V, Koul N, Sen E (2008) Involvement of Miltefosine mediated ERK activation in glioma cell apoptosis through Fas regulation. J Neurochem 107(3):616–627Google Scholar
- 15.Sen E (2011) Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy. Drug Discov Today 16(23–24):1044–1051Google Scholar
- 16.Sharma V, Koul N, Joseph C, Dixit D, Ghosh S, Sen E (2009) HDAC inhibitor Scriptaid induces glioma cell apoptosis through JNK activation and inhibits telomerase activity. J Cell Mol Med 14(8):2151–2161Google Scholar
- 17.Sharma V, Dixit D, Koul N, Mehta VS, Sen E (2011) Ras regulates interleukin-1beta-induced HIF-1alpha transcriptional activity in glioblastoma. J Mol Med (Berl) 89(2):123–136Google Scholar
- 18.Sun H, Zhong YJ, Zheng XL, Wang Q, Yang L, Shi F et al (2012) Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells. Cancer Sci 103(2):197–202Google Scholar